LifeCyte Innovations develops therapies targeting chronic inflammation to slow age-related diseases, including AMD and cognitive decline.
LifeCyte Innovations has raised $1.0M in total funding. The most recent round was Seed. The last funding was announced in August 2026.
LifeCyte Innovations is headquartered in Greensboro, United States.
LifeCyte Innovations develops therapies targeting chronic inflammation to slow age-related diseases, including AMD and cognitive decline.
LifeCyte Innovations is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"LifeCyte Innovations — Funding & Investors." VCBacked, August 19, 2026, https://www.vcbacked.co/company/lifecyte-innovations. Accessed October 22, 2026.
VCBacked. (2026). LifeCyte Innovations — Funding & Investors. Retrieved October 22, 2026, from https://www.vcbacked.co/company/lifecyte-innovations
{{cite web |title=LifeCyte Innovations — Funding & Investors |url=https://www.vcbacked.co/company/lifecyte-innovations |website=VCBacked |access-date=October 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated